Anti-NMDAR autoimmune encephalitis

Bliss, 1993, A synaptic model of memory: long-term potentiation in the hippocampus, Nature, 361, 31, 10.1038/361031a0 Komuro, 1993, Modulation of neuronal migration by NMDA receptors, Science, 260, 95, 10.1126/science.8096653 Mori, 1995, Structure and function of the NMDA receptor channel, Neuropharmacology, 34, 1219, 10.1016/0028-3908(95)00109-J Lancelot, 1998, Glutamate toxicity in chronic neurodegenerative disease, Prog Brain Res, 116, 331, 10.1016/S0079-6123(08)60446-X Gunduz-Bruce, 2009, The acute effects of NMDA antagonism: from the rodent to the human brain, Brain Res Rev, 60, 279, 10.1016/j.brainresrev.2008.07.006 Coyle, 2003, Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia, Ann NY Acad Sci, 1003, 318, 10.1196/annals.1300.020 Brierley, 1960, Subacute encephalitis of later adult life. Mainly affecting the linbic areas, Brain, 83, 357, 10.1093/brain/83.3.357 Newman, 1990, Paraneoplastic limbic encephalitis: neuropsychiatric presentation, Biol Psychiatry, 27, 529, 10.1016/0006-3223(90)90444-7 Buckley, 2001, Potassium channel antibodies in two patients with reversible limbic encephalitis, Ann Neurol, 50, 73, 10.1002/ana.1097 Irani, 2010, Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia, Brain, 133, 2734, 10.1093/brain/awq213 Takahashi, 2003, Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua, Neurology, 61, 891, 10.1212/01.WNL.0000086819.53078.70 Dalmau, 2007, Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol, 61, 25, 10.1002/ana.21050 Dale, 2009, N-methyl-d-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica, Ann Neurol, 66, 704, 10.1002/ana.21807 Florance, 2009, Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents, Ann Neurol, 66, 11, 10.1002/ana.21756 Pruss, 2010, Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin, Neurology, 75, 1735, 10.1212/WNL.0b013e3181fc2a06 Day, 2011, Anti-NMDA-receptor encephalitis: case report and literature review of an under-recognized condition, J Gen Intern Med, 26, 811, 10.1007/s11606-011-1641-9 Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol, 7, 1091, 10.1016/S1474-4422(08)70224-2 Titulaer, 2013, Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study, Lancet Neurol, 12, 157, 10.1016/S1474-4422(12)70310-1 Bien, 2012, Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis, Brain, 135, 1622, 10.1093/brain/aws082 Davis, 2013, Autoimmunity, seizures, and status epilepticus, Epilepsia, 54, 46, 10.1111/epi.12276 Granerod, 2010, Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study, Lancet Infect Dis, 10, 835, 10.1016/S1473-3099(10)70222-X Irani, 2010, N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes, Brain, 133, 1655, 10.1093/brain/awq113 Gable, 2012, The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project, Clin Infect Dis, 54, 899, 10.1093/cid/cir1038 Tsutsui, 2012, Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features, BMC Psychiatry, 12, 37, 10.1186/1471-244X-12-37 Steiner, 2013, Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis, JAMA Psychiatry, 70, 271, 10.1001/2013.jamapsychiatry.86 Barry, 2011, Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis, Br J Psychiatry, 199, 508, 10.1192/bjp.bp.111.092197 Stepulak, 2009, Expression of glutamate receptor subunits in human cancers, Histochem Cell Biol, 132, 435, 10.1007/s00418-009-0613-1 Li, 2013, Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion, Cell, 153, 86, 10.1016/j.cell.2013.02.051 Prickett, 2012, Molecular pathways: dysregulated glutamatergic signaling pathways in cancer, Clin Cancer Res, 18, 4240, 10.1158/1078-0432.CCR-11-1217 Armangue, 2013, Pediatric anti-N-methyl-d-aspartate receptor encephalitis – clinical analysis and novel findings in a series of 20 patients, J Pediatr, 162, 850, 10.1016/j.jpeds.2012.10.011 Turner, 2011, Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies, Neurology, 77, 439, 10.1212/WNL.0b013e318227b176 Schmitt, 2012, Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis, Neurology, 79, 1094, 10.1212/WNL.0b013e3182698cd8 Goldberg, 2011, Anti-NMDA receptor encephalitis presenting with focal non-convulsive status epilepticus in a child, Neuropediatrics, 42, 188, 10.1055/s-0031-1295408 Kirkpatrick, 2011, Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis, Epilepsy Behav, 20, 392, 10.1016/j.yebeh.2010.11.020 Morooka, 2012, 18F-FDG and 11C-methionine PET/CT findings in a case with anti-NMDA (NR2B) receptor encephalitis, Clin Nucl Med, 37, 400, 10.1097/RLU.0b013e3182443c92 Takano, 2011, Detection of autoantibody against extracellular epitopes of N-methyl-d-aspartate receptor by cell-based assay, Neurosci Res, 71, 294, 10.1016/j.neures.2011.07.1834 Anegawa, 1995, Transfection of N-methyl-d-aspartate receptors in a nonneuronal cell line leads to cell death, J Neurochem, 64, 2004, 10.1046/j.1471-4159.1995.64052004.x Suh-Lailam, 2013, Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay, Clin Chim Acta, 421, 1, 10.1016/j.cca.2013.02.010 Dalmau, 2011, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, Lancet Neurol, 10, 63, 10.1016/S1474-4422(10)70253-2 Pham, 2011, Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis, J Clin Apher, 26, 320, 10.1002/jca.20311 Ikeguchi, 2012, Rituximab used successfully in the treatment of anti-NMDA receptor encephalitis, Intern Med, 51, 1585, 10.2169/internalmedicine.51.6874 Kashyape, 2012, Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients, Eur J Paediatr Neurol, 16, 74, 10.1016/j.ejpn.2011.07.005 Seki, 2008, Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis, J Neurol Neurosurg Psychiatry, 79, 324, 10.1136/jnnp.2007.136473 Leypoldt, 2013, Recovery from severe frontotemporal dysfunction at 3years after N-methyl-d-aspartic acid (NMDA) receptor antibody encephalitis, J Clin Neurosci, 20, 611, 10.1016/j.jocn.2012.03.036 Poloni, 2010, Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-d-aspartate receptor encephalitis, Dev Med Child Neurol, 52, 78, 10.1111/j.1469-8749.2009.03542.x Gabilondo, 2011, Analysis of relapses in anti-NMDAR encephalitis, Neurology, 77, 996, 10.1212/WNL.0b013e31822cfc6b Hughes, 2010, Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis, J Neurosci, 30, 5866, 10.1523/JNEUROSCI.0167-10.2010 Xu, 2011, Anti-N-methyl-d-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein–Barr virus viral capsid antigen: a case report and one year follow-up, BMC Neurol, 11, 149, 10.1186/1471-2377-11-149 Martinez-Hernandez, 2011, Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis, Neurology, 77, 589, 10.1212/WNL.0b013e318228c136 Camdessanche, 2011, Brain immunohistopathological study in a patient with anti-NMDAR encephalitis, Eur J Neurol, 18, 929, 10.1111/j.1468-1331.2010.03180.x Dale, 2013, Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-d-aspartate receptor encephalitis, Dev Med Child Neurol, 55, 191, 10.1111/dmcn.12036 Mikasova, 2012, Disrupted surface cross-talk between NMDA and ephrin-B2 receptors in anti-NMDA encephalitis, Brain, 135, 1606, 10.1093/brain/aws092